XG7-29517-26027
4 vaccinations
5 coded responses
24 check-ins
4 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 040 / ME
- Registered
- 2020-12-18
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-18
Registered in v-safe
-
2020-12-18
Dose 1 — Pfizer-BioNTech
- 2020-12-18
- 2020-12-19
- 2020-12-20
- 2020-12-21
- 2020-12-22
- 2020-12-23
-
2020-12-24
Survey response — days 1–6 daily, dose 1MedDRA: COVID-19 — Feeling: Fair · Headache, Muscle or body aches · Be unable to workFree text: Positive for COVID 19MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2020-12-24
-
2020-12-25
Survey response — day 7, dose 1MedDRA: COVID-19 — Feeling: Fair · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to workFree text: Positive for COVID-19MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2020-12-25
- 2021-01-01
-
2021-01-08
Dose 2 — Pfizer-BioNTech
- 2021-01-15
- 2021-01-22
- 2021-01-29
-
2021-02-05
Survey response — day 28, dose 2MedDRA: Rhinorrhoea — Feeling: GoodFree text: New runny noseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-12
- 2021-02-19
- 2021-04-09
- 2021-07-09
-
2021-10-11
Dose 3 — Pfizer-BioNTech
- 2022-01-08
-
2022-09-13
Dose 4 — Pfizer-BioNTech
- 2022-10-04
- 2022-10-11
- 2022-10-18
-
2022-10-25
Survey response — day 42, dose 4MedDRA: Nasopharyngitis — Feeling: FairFree text: ColdMedDRA releases: 2024-11 · check-in free text available
- 2022-12-13
- 2023-03-14
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-18 | Pfizer-BioNTech | |
| 2 | 2021-01-08 | Pfizer-BioNTech | |
| 3 | 2021-10-11 | Pfizer-BioNTech | No |
| 4 | 2022-09-13 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2020-12-24 | priority 2/3 | |
| 2020-12-25 | priority 2/3 |
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Positive for COVID 19
Release 1 — day 7, dose 1
Systemic reaction (other): Positive for COVID-19
Release 3 — day 28, dose 2
Symptoms: New runny nose
Release 12 — day 42, dose 4
Symptoms: Cold
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SD | Rhinorrhoea | ✓ | ✓ | ✓ |
| SRO | COVID-19 | ✓ | ✓ | ✓ |
| SRO | SARS-CoV-2 test positive | ○ | ○ | ○ |
✓ active code · ○ coded but marked inactive · blank = not in that release